نتایج جستجو برای: reteplase

تعداد نتایج: 161  

2018
Zhi-Jian Lin Hong-Yan Qiu Xiao-Xin Tong Yi Guo Man-Fu Han Chun-Shui Yang Kai-Hua Lin Jun Wu Xing Li Yang Yang

Objective: The present study aimed to investigate the efficacy and safety of Reteplase (rPA) and Alteplase (rt-PA) in the treatment of hyper-acute cerebral infarction (CI).Methods: Six hundred and eleven patients with hyper-acute CI selected from September 2014 to September 2016 were assigned into the aspirin, rt-PA, rPA, rt-PA + aspirin, and rPA + aspirin groups based on their willingness. The...

2014
Stavropoula I. Tjoumakaris Pascal M. Jabbour Aaron S. Dumont L. Fernando Gonzalez Robert H. Rosenwasser Thomas Jefferson

Stroke is a major cause of serious, long-term disability and the third leading cause of death in the United States1. According to the World Health Organization, 15 million people suffer a stroke worldwide annually. Of those, one third do not survive and another third is left with a significant neurological deficit. The majority of these events are ischemic (87%), as opposed to intracerebral (10...

Journal: :Chest 2008
Shaun G Goodman Venu Menon Christopher P Cannon Gabriel Steg E Magnus Ohman Robert A Harrington

This chapter about fibrinolytic, antiplatelet, and antithrombin treatment for acute ST-segment elevation (STE) myocardial infarction (MI) is part of the American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Grade 1 recommendations are strong and indicate that the benefits do, or do not, outweigh risks, burden, and costs. Grade 2 suggests that individual...

Journal: :Heart 1997
K Schröder K Wegscheider K L Neuhaus U Tebbe R Schröder

OBJECTIVE To evaluate the benefit to risk ratio of thrombolytic treatment in patients with small inferior acute myocardial infarction (AMI). Controlled studies relating the benefit from thrombolysis with initial electrocardiographic features are scarce and of limited sample size. DESIGN Retrospective study of 728 patients with a first inferior AMI of six hours' duration from the Intravenous S...

Journal: :Haematologica 2012
Jacquelyn L Baskin Ulrike Reiss Judith A Wilimas Monika L Metzger Raul C Ribeiro Ching-Hon Pui Scott C Howard

BACKGROUND Long-term central venous catheters have improved the quality of care for patients with chronic illnesses, but are complicated by obstructions which can result in delay of treatment or catheter removal. DESIGN AND METHODS This paper reviews thrombolytic treatment for catheter obstruction. Literature from Medline searches using the terms "central venous catheter", "central venous acc...

2012
Maija T. Mäki Juha W. Koskenvuo Heikki Ukkonen Antti Saraste Helena Tuunanen Mikko Pietilä Sergey V. Nesterov Ville Aalto K. E. Juhani Airaksinen Jussi P. Pärkkä Riikka Lautamäki Kari Kervinen Johanna A. Miettinen Timo H. Mäkikallio Matti Niemelä Marjaana Säily Pirjo Koistinen Eeva-Riitta Savolainen Kari Ylitalo Heikki V. Huikuri Juhani Knuuti

PURPOSE Beneficial mechanisms of bone marrow cell (BMC) therapy for acute ST-segment elevation myocardial infarct (STEMI) are largely unknown in humans. Therefore, we evaluated the feasibility of serial positron emission tomography (PET) and MRI studies to provide insight into the effects of BMCs on the healing process of ischemic myocardial damage. METHODS Nineteen patients with successful p...

Journal: :The Journal of biological chemistry 1999
V Sinniger R E Merton P Fabregas J Felez C Longstaff

A number of cell types have previously been shown to bind tissue plasminogen activator (tPA), which in some cases can remain active on the cell surface resulting in enhanced plasminogen activation kinetics. We have investigated several cultured cell lines, U937, THP1, K562, Molt4, and Nalm6 and shown that they bind both tPA and plasminogen and are able to act as promoters of plasminogen activat...

Journal: :Stroke 2005
Carlos A Molina Jeffrey L Saver

BACKGROUND AND PURPOSE Reperfusion is the most beneficial of all therapeutic strategies for acute ischemic stroke. However, the standard cerebral reperfusion treatment of the first decade of the reperfusion era, noncontrast computed tomography (CT)-guided, < or =3 hours, intravenous tissue plasminogen activator, has many limitations. This review surveys emerging strategies that have the potenti...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید